0
Poster Walks: Poster Walk 8: Interstitial lung disease/ICU/Pediatrics |

P241 Validation of APPS tool to predict mortality in moderate and severe acute respiratory distress syndrome

V. Jayaschandran; E. Schuiteman; E. Otoupalova; S. Ginoya; J. Boura; B. Dalal
Author and Funding Information

William Beaumont Hospital, Royal Oak, United States


Copyright 2017, American College of Chest Physicians and Swiss Respiratory Society SGP. All Rights Reserved.


Chest. 2017;151(5_S):A141. doi:10.1016/j.chest.2017.04.148
Text Size: A A A
Published online

Extract

Introduction: A prediction tool that was developed by Villar et al. in Spain called ‘APPS’ tool was shown to accurately predict in-hospital mortality in moderate and severe Acute Respiratory Syndrome (ARDS) patients on lung-protective ventilation. A simple 9-point score that utilized the variables of age, PaO2/FiO2 ratio and Plateau pressure measured at 24 hours after diagnosis of ARDS divided patients into groups of low, moderate and high mortality risk. We have attempted to validate APPS tool to correlate mortality in a cohort of ARDS patients at a tertiary care hospital in the US.

First Page Preview

View Large
First page PDF preview

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
CHEST Journal Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543